Back

High-sensitivity troponin (hs-Tn) for cardiovascular risk prognostication: a systematic review and meta-analysis

29 August 2022 (09:15 - 10:00)
Organised by:
Congress Presentation Part of: Cardiovascular risk assessment - Biomarkers 2 Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marios Sagris

Hippokration General Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Long-term prognostic value of trimethylamine N-oxide in community-based adults and patients with coronary heart disease
Doctor E. Bjornestad (Stavanger, NO)
Abstract Slides
Presentation thumbnail
Ultra-sensitive troponin-I and incident coronary heart disease, stroke, heart failure, cardiac arrhythmias, arterial aneurysms and venous thromboembolism hospitalizations
Professor J. Empana (Paris, FR)
Abstract Slides
Presentation thumbnail
The effect of ziltivekimab on the neutrophil-lymphocyte ratio: analysis from RESCUE
Doctor N. Adamstein (Boston, US)
Abstract Slides
Presentation thumbnail
High-sensitive Troponin T is not associated with the progression of asymptomatic mild to moderate aortic stenosis: a post hoc substudy of the SEAS trial
Doctor E. Hadziselimovic (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease
Professor J. Bergler-Klein (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk assessment - Biomarkers 2

The Event

Event poster

ESC Congress 2022

29 August 2022 09:15 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources